About 1,091,100 doses of COVID-19 vaccines have been administered to the public, with about 719,900 people receiving their first dose and about 371,200 people getting their second dose. Among those given the first dose of vaccines, about 375,600 people have received the Sinovac jab and about 344,300 people have received the BioNTech one. For the second dose, about 223,100 people have received the Sinovac vaccine, while about 148,100 people have been administered the BioNTech jab. About 3,600 people received their first dose of the Sinovac vaccine under the COVID-19 Vaccination Programme today. Among them, about 3,200 people received the jab at eight community vaccination centres (CVCs), while about 400 were inoculated at private doctors and clinics participating in the programme. Around 10,400 people received their second dose of the Sinovac vaccine today, including about 9,800 people vaccinated at CVCs and about 600 people through private doctors and clinics.
The Government today said it is gravely concerned about the European Union's (EU) announcement of implementing an export control mechanism, and if necessary, banning the export of COVID-19 vaccines.
The EU's announcement stated that it will strive to ensure the new regulation does not affect the exports under advance purchase agreements already entered into between vaccine manufacturers and third parties.
The Government has proactively followed up with the vaccine manufacturers it has advance purchase agreements with to ensure that the vaccines procured can be supplied to Hong Kong as scheduled.
It has indicated to Fosun Pharma that it should reach out to the various relevant parties to ensure that the Fosun/BioNTech vaccine to be exported for supply to Hong Kong under the advance purchase agreement will not be affected.
The Government will closely monitor the development of the situation.
It will also continue to negotiate purchase agreements with vaccine manufacturers from around the world and the Mainland to obtain more supplies of vaccines which meet the criteria of safety, efficacy and quality, and strive for the early supply of the vaccines to Hong Kong.
http://dlvr.it/RrjBfd
http://dlvr.it/RrjBfd